超导磁体龙头健信超导科创板IPO：推动国产替代，助力产业升级

Group 1: Company Overview - Ningbo Jianxin Superconducting Technology Co., Ltd. (referred to as "Jianxin Superconducting") is preparing for its IPO review on the Sci-Tech Innovation Board, focusing on the R&D, production, and sales of core components for MRI equipment [1] - The company is one of the earliest manufacturers in China to scale the production of high-field superconducting magnets, breaking the long-standing monopoly of foreign manufacturers in the 1.5T superconducting magnet sector since 2015 [1][4] - Jianxin Superconducting has established itself as the largest independent supplier of superconducting magnets globally, with a projected global market share ranking of fifth and second among domestic companies in 2024 [1][6] Group 2: Market Dynamics - The global MRI equipment market is expected to grow from $11.1 billion in 2024 to $14.89 billion by 2030, with a compound annual growth rate (CAGR) of approximately 5.0% [2] - The Chinese MRI equipment market has seen growth from 10.45 billion yuan in 2015 to 16.6 billion yuan in 2024, with an anticipated CAGR of 5.3%, further projected to reach 22.76 billion yuan by 2030 [2] - Superconducting MRI devices are the mainstream type in the domestic market, expected to account for over 90% of the total installed capacity in 2024 [2] Group 3: Policy and Technological Support - Recent national policies have supported the development of medical equipment, particularly encouraging innovation in domestic medical devices and focusing on core components as key areas for advancement [3] - The MRI equipment market is experiencing a favorable development phase driven by demand growth, policy encouragement, and technological innovation [3] Group 4: Technological Advancements - Jianxin Superconducting has developed a comprehensive core technology system, including electromagnetic field design, cryogenic technology, finite element analysis, structural design, intelligent control technology, and manufacturing processes [4] - The company has achieved significant advancements in superconducting technology, including the development of a fully helium-free superconducting magnet, recognized as the "first of its kind" in 2021 [5] Group 5: Financial Performance and Growth - Jianxin Superconducting has established strong partnerships with notable MRI equipment manufacturers, contributing to stable product demand and a robust sales channel [7] - The company's revenue has shown a consistent upward trend from 359 million yuan in 2022 to 425 million yuan in the first half of 2025, with net profits also increasing during the same period [7] - The company aims to raise funds through its IPO to enhance R&D and product innovation, focusing on projects such as the annual production of 600 helium-free superconducting magnets [8]